Sensus Healthcare, Inc. (SRTS)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenues | 7,315 | 8,344 | 8,839 | 9,239 |
| Cost of sales | 4,412 | 3,990 | - | - |
| Cost of revenue | - | - | 3,599 | 3,816 |
| Gross profit | 2,903 | 4,354 | 5,240 | 5,423 |
| General and administrative expense | - | - | 1,573 | 1,579 |
| General and administrative | 1,986 | 2,208 | - | - |
| Selling and marketing | 1,389 | 2,186 | 1,309 | 996 |
| Research and development | 1,471 | 2,606 | 863 | 866 |
| Total operating expenses | 4,846 | 7,000 | 3,745 | 3,441 |
| (loss) income from operations | -1,943 | -2,646 | 1,495 | 1,982 |
| Investment income, interest | - | - | 279 | 209 |
| Interest income, net | -183 | -184 | - | - |
| Other income, net | 183 | 184 | 279 | 209 |
| (loss) income before income tax | -1,760 | -2,462 | 1,774 | 2,191 |
| (benefit from) provision for income taxes | -723 | 110 | 559 | 579 |
| Net (loss) income | -1,037 | -2,572 | 1,215 | 1,612 |
| Net income (loss) per share - basic | -0.06 | -0.16 | 0.07 | 0.1 |
| Net income (loss) per share - diluted | -0.06 | -0.16 | 0.07 | 0.1 |
| Weighted average number of shares used in computing net income (loss) per share - basic | 16,320,036 | 16,341,867 | 16,321,131 | 16,298,459 |
| Weighted average number of shares used in computing net income (loss) per share - diluted | 16,320,036 | 16,341,867 | 16,345,749 | 16,333,481 |